IAL Biolytix and Innaphase Corporation Sign Agreement to Implement the Watson™ Laboratory Information Management System

 

PHILADELPHIA, September 3, 2003 / — InnaPhase Corporation, the world’s largest provider of Laboratory Information Management Systems (LIMS) for the pharmaceutical industry, today announced that IAL Biolytix, has signed a license agreement to implement InnaPhase’s WatsonTM Laboratory Information Management System for their Monmouth Junction, New Jersey facility in the United States.

Watson™ LIMS, a solution within the Pharma LIMS™ Suite, is specifically designed to support DMPK/Bioanalytical studies in drug development while ensuring regulatory compliance with the FDA’s 21 CFR Part 11 guidance on electronic records and signatures. Watson LIMS has an established track record of accelerating bioanalysis, sample management and regulatory compliance in pharmaceutical drug development.

“Being a fairly new contract research organization, we realized very quickly the importance of using an industry standard solution such Watson LIMS,” said Dari Dadgar, Ph.D and President of IAL Biolytix. “We continue to be impressed with Watson’s features including the flexible design studies, automated sample management and seamless data exchange among others.”

IAL Biolytix was founded in 2002 by Dari Dadgar, Ph.D. and Pamela Burnett and is located in Monmouth Junction, New Jersey. The company’s 4,000 Sq. Ft. laboratory operates under full compliance with GLP rules through SOP’s and is dedicated to quality bioanalysis through good science, access to the latest technology and personal service. For more information on IAL Biolytix, contact dari@ial-biolytix.com.

InnaPhase Corporation provides 18 of the world’s top 20 pharmaceutical organizations with its products and services. The Pharma LIMS ™ Suite is a series of purpose built LIMS applications for the pharmaceutical industry and is designed to operate in a 21 CFR Part 11 compliant environment. The Pharma LIMS Suite includes: Newton™ LIMS for batch release, quality control, formulation, stability and analytical development; Watson™ LIMS for pre-clinical and clinical bioanalysis; and Galileo™ LIMS for In Vitro testing. InnaPhase also markets LabManager iLIMS as well as PeakPro and Pinnacle Chromatography Data Systems. InnaPhase has locations in the United States, the United Kingdom and distribution centers in India and Japan. For more information, see InnaPhase on the worldwide web at www.innaphase.com

NOTE TO EDITORS:
For a complete media information kit on InnaPhase Products and Services, contact Karen Horan at InnaPhase Corporation, 215-964-6055 or e-mail khoran@innaphase.com.